Published in Genome Med on September 25, 2012
Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia. Front Synaptic Neurosci (2014) 0.87
Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient. Endocrinol Diabetes Metab Case Rep (2016) 0.87
Somatic mutations in disorders with disrupted brain connectivity. Exp Mol Med (2016) 0.76
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay. Am J Hum Genet (2017) 0.75
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res (2008) 26.04
Origins and functional impact of copy number variation in the human genome. Nature (2009) 23.63
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science (2010) 18.45
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet (2010) 12.63
Rate of de novo mutations and the importance of father's age to disease risk. Nature (2012) 11.92
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron (2011) 10.61
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry (2003) 10.44
Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet (2008) 10.19
De novo gene disruptions in children on the autistic spectrum. Neuron (2012) 9.69
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
A de novo paradigm for mental retardation. Nat Genet (2010) 8.57
A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med (2011) 8.26
Schizophrenia. Lancet (2009) 8.14
Performance comparison of exome DNA sequencing technologies. Nat Biotechnol (2011) 7.11
Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A (2010) 7.07
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell (1990) 6.94
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (1993) 6.67
The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet (2000) 6.44
De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet (2010) 5.72
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet (2001) 5.61
Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet (2007) 5.04
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat Genet (2011) 4.67
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet (2001) 4.63
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med (1998) 4.29
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med (2012) 3.94
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
De novo mutations in human genetic disease. Nat Rev Genet (2012) 3.81
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry (2006) 3.63
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Non-invasive prenatal measurement of the fetal genome. Nature (2012) 3.11
High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron (2011) 3.08
Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet (2011) 2.86
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 2.62
Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet (1999) 2.42
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients. Hum Mol Genet (2003) 2.17
Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet (2004) 1.88
Paternal origin of FGFR2 mutations in sporadic cases of Crouzon syndrome and Pfeiffer syndrome. Am J Hum Genet (2000) 1.85
Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet (1994) 1.79
A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet (1999) 1.69
De novo copy number variants associated with intellectual disability have a paternal origin and age bias. J Med Genet (2011) 1.69
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet (2011) 1.63
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat (2010) 1.49
MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet (2001) 1.45
The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord (2010) 1.45
Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol (2002) 1.39
Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome. Eur J Hum Genet (2005) 1.38
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell (1993) 1.38
De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol (2000) 1.36
Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet (1996) 1.31
Age and sex effects on human mutation rates: an old problem with new complexities. J Radiat Res (2006) 1.30
Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum Mol Genet (2012) 1.29
De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology (2010) 1.20
Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy. Clin Genet (2009) 1.17
Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations. Ann Neurol (2001) 1.14
Reproductive patterns in psychotic patients. Schizophr Res (2010) 1.13
Cell-free fetal nucleic acid testing: a review of the technology and its applications. Obstet Gynecol Surv (2011) 1.07
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging (2010) 1.04
Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening. J Med Screen (2004) 1.01
Parental origin of de novo MECP2 mutations in Rett syndrome. Eur J Hum Genet (2001) 1.01
A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet (1997) 1.01
X chromosome linkage studies in familial Rett syndrome. Hum Genet (1993) 0.90
Decisional needs assessment regarding Down syndrome prenatal testing: a systematic review of the perceptions of women, their partners and health professionals. Prenat Diagn (2008) 0.85
Genomic medicine and neurological disease. Hum Genet (2011) 0.85
Déjérine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat (1995) 0.82
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementia. J Neurol Neurosurg Psychiatry (2007) 0.79
Exome sequencing: a transient technology for molecular diagnostics? Expert Rev Mol Diagn (2012) 0.78
Focal epilepsy resulting from a de novo SCN1A mutation. Neuropediatrics (2007) 0.76